Bioxytran, Inc
BIXT- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001445815
No open-market purchases or sales by Bioxytran, Inc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding BIXT, Q2 2026
No superinvestor reported holding BIXT at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Bioxytran, Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2025 (view filing)4:15 PM ET | Nov 18 | Same day | Hoberman Alan MDirector | PPurchasecommon | +210.0K | $0.60 | +$126.0K | New position210.0K after | |
| Aug 20, 2024 (view filing)5:10 PM ET | Aug 15 | 5 daysLate | Platt DavidCEO | PPurchasecommon | +1.59M | $0.124 | +$197.5K | +7.9%21.7M after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Bioxytran, Inc at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding BIXT in 13F filings for Q2 2026.